Jonathan Yingling
Chief Tech/Sci/R&D Officer at ARCUS BIOSCIENCES, INC.
Jonathan Yingling active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ARCUS BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 31/12/2019 | - |
Career history of Jonathan Yingling
Former positions of Jonathan Yingling
| Companies | Position | Start | End |
|---|---|---|---|
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Chief Tech/Sci/R&D Officer | 31/12/2017 | 30/01/2020 |
| Corporate Officer/Principal | 05/02/2017 | 31/12/2017 | |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 31/05/2013 | 30/09/2015 |
| DNIB UNWIND INC | Chief Tech/Sci/R&D Officer | 15/12/2015 | - |
Training of Jonathan Yingling
| Duke University School of Medicine | Doctorate Degree |
| The College of William & Mary | Undergraduate Degree |
Statistics
International
| United States | 7 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ARCUS BIOSCIENCES, INC. | Health Technology |
| Private companies | 2 |
|---|---|
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA. | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
- Stock Market
- Insiders
- Jonathan Yingling
- Experience